Kobayashi Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	165,742	165,600	173,455	166,258	155,252
Revenue Growth (YoY)	0.09%	-4.53%	4.33%	7.09%	3.15%
Cost of Revenue	81,030	77,997	77,079	73,927	66,478
Gross Profit	84,712	87,603	96,376	92,331	88,774
Selling, General & Admin	54,126	48,040	57,457	53,902	52,072
Research & Development	9,122	9,109	9,004	8,327	7,522
Amortization of Goodwill & Intangibles	1,390	1,407	1,128	998	862
Other Operating Expenses	1,264	753	930	767	718
Operating Expenses	69,788	62,893	70,749	65,825	62,823
Operating Income	14,924	24,710	25,627	26,506	25,951
Interest Expense	-28	-28	-29	-18	-18
Interest & Investment Income	999	815	762	578	588
Currency Exchange Gain (Loss)	278	330	40	231	481
Other Non Operating Income (Expenses)	821	1,033	930	983	1,011
EBT Excluding Unusual Items	16,994	26,860	27,330	28,280	28,013
Gain (Loss) on Sale of Investments	3,041	635	436	-89	84
Gain (Loss) on Sale of Assets	-12,516	-51	-59	-52	-70
Asset Writedown	-140	-	-59	-69	-309
Other Unusual Items	-3,636	-13,531	-89	-121	-83
Pretax Income	3,743	13,913	27,559	27,949	27,635
Income Tax Expense	83	3,842	7,221	7,927	7,920
Earnings From Continuing Operations	3,660	10,071	20,338	20,022	19,715
Minority Interest in Earnings	-4	-4	-	-	-
Net Income	3,656	10,067	20,338	20,022	19,715
Net Income to Common	3,656	10,067	20,338	20,022	19,715
Net Income Growth	-63.68%	-50.50%	1.58%	1.56%	2.66%
Shares Outstanding (Basic)	74	74	76	77	78
Shares Outstanding (Diluted)	74	74	76	77	78
Shares Change (YoY)	0.00%	-1.98%	-1.67%	-1.27%	-0.05%
EPS (Basic)	49.18	135.42	268.16	259.61	252.35
EPS (Diluted)	49.18	135.42	268.16	259.59	252.35
EPS Growth	-63.68%	-49.50%	3.30%	2.87%	2.71%
Free Cash Flow	-	-14,810	5,604	17,167	18,756
Free Cash Flow Per Share	-	-199.22	73.89	222.57	240.08
Dividend Per Share	-	102.000	101.000	90.000	83.000
Dividend Growth	-	0.99%	12.22%	8.43%	7.79%
Gross Margin	51.11%	52.90%	55.56%	55.54%	57.18%
Operating Margin	9.00%	14.92%	14.77%	15.94%	16.71%
Profit Margin	2.21%	6.08%	11.72%	12.04%	12.70%
Free Cash Flow Margin	-	-8.94%	3.23%	10.33%	12.08%
EBITDA	22,946	32,732	31,684	31,864	30,786
EBITDA Margin	13.84%	19.77%	18.27%	19.16%	19.83%
D&A For EBITDA	8,022	8,022	6,057	5,358	4,835
EBIT	14,924	24,710	25,627	26,506	25,951
EBIT Margin	9.00%	14.92%	14.77%	15.94%	16.71%
Effective Tax Rate	2.22%	27.61%	26.20%	28.36%	28.66%
Advertising Expenses	16,862	11,575	23,038	22,389	22,499

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.